RCKT Rocket Pharmaceuticals, Inc. Net Sales Margin

Rocket Pharmaceuticals, Inc. - graphic logo of issuer RCKT

Net profit sales returns on this GURU.Markets chart demonstrate yield dynamics where 0.00 serves as the base parameter value. Rocket Pharmaceuticals (RCKT) is protected by its humanitarian status and stable US law. Rocket Pharmaceuticals (RCKT) creates unique one-time treatments for fatal blood and heart pathologies. A team of elite geneticists is motivated by generous bonuses and the opportunity to actually save children's lives.

Rocket Corp (RCKT) - Return on Sales by Net Profit from 07/04/2022 to 11/19/2026

RCKT (Rocket Pharmaceuticals): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental company valuation:Rocket Pharma - RCKT
Finished products of Rocket Corp

Automation of gene therapy synthesis at Rocket Pharmaceuticals (RCKT) optimizes costs, yet the high expense of medical supervision directly impacts the net profit margin. This metric reflects the portion of net profit in every dollar of revenue, allowing investors to assess capital management efficiency and the resilience of cash flows against long-term risks while ignoring short-term volatile impulses.

Competitors of Rocket Pharmaceuticals (RCKT)

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX